These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23666892)

  • 21. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
    Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA: a novel biomarker and therapeutic target to combat autophagy in diabetic nephropathy.
    Ma J; Wang Y; Xu HT; Ren N; Zhao N; Wang BM; Du LK
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6257-6263. PubMed ID: 31364128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA profiling for the early detection and clinical monitoring of diabetic kidney disease.
    DiStefano JK
    Biomark Med; 2017 Feb; 11(2):99-102. PubMed ID: 28097875
    [No Abstract]   [Full Text] [Related]  

  • 24. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs in kidney physiology and disease.
    Trionfini P; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs: potential mediators and biomarkers of diabetic complications.
    Kato M; Castro NE; Natarajan R
    Free Radic Biol Med; 2013 Sep; 64():85-94. PubMed ID: 23770198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and detection of microRNA kidney disease biomarkers in liquid biopsies.
    Smith DA; Redman JE; Fraser DJ; Bowen T
    Curr Opin Nephrol Hypertens; 2023 Nov; 32(6):515-521. PubMed ID: 37678380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
    Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
    Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
    Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
    Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy in humans: pathologic diversity.
    Valk EJ; Bruijn JA; Bajema IM
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):285-9. PubMed ID: 21422920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.
    Zhang Y; Sun X; Icli B; Feinberg MW
    Endocr Rev; 2017 Apr; 38(2):145-168. PubMed ID: 28323921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Signaling of Cellular Senescence in Diabetic Nephropathy.
    Xiong Y; Zhou L
    Oxid Med Cell Longev; 2019; 2019():7495629. PubMed ID: 31687085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.
    Cardenas-Gonzalez M; Srivastava A; Pavkovic M; Bijol V; Rennke HG; Stillman IE; Zhang X; Parikh S; Rovin BH; Afkarian M; de Boer IH; Himmelfarb J; Waikar SS; Vaidya VS
    Clin Chem; 2017 Sep; 63(9):1515-1526. PubMed ID: 28667184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
    Zheng Z; Guan M; Jia Y; Wang D; Pang R; Lv F; Xiao Z; Wang L; Zhang H; Xue Y
    Sci Rep; 2016 Nov; 6():37492. PubMed ID: 27874055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of circular RNAs in diabetic complications: From molecular mechanisms to therapeutic potential.
    Zhang JR; Sun HJ
    Gene; 2020 Dec; 763():145066. PubMed ID: 32827686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNAs in chronic kidney disease.
    Zhao H; Ma SX; Shang YQ; Zhang HQ; Su W
    Clin Chim Acta; 2019 Apr; 491():59-65. PubMed ID: 30639583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Regulations in Diabetic Nephropathy.
    Lu Z; Liu N; Wang F
    J Diabetes Res; 2017; 2017():7805058. PubMed ID: 28401169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.